Retail Hiring Surges in April But Consumer Caution Flags Potential Slowdown Burberry Shares Climb on Report of Potential Moncler Takeover Bid Consumer Credit Growth Surges in December Signaling Strong Spending Samsung Electronics Strike Suspended as Workers Vote on Deal Including AI Bonus Demand Geopolitical Shift Iran Emerges Stronger in US Negotiations Morgan Stanley Signals Potential Turnaround for Franklin Resources BEN STWD Q1 2026 Earnings EPS Misses Estimates Amid Challenging CRE Environment SKWD Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower LUCY Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Market Reaction Septerna Inc SEPN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline ClearSign Technologies Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Edges Higher Fractyl Health Inc GUTS Q1 2026 Earnings Narrower Loss Surprises Stock Slides CRA International CRAI Edges Higher Navigating Key Support and Resistance Levels Freshpet Inc FRPT Edges Higher Amid Consolidation Near Key Resistance Levels Saba Capital Income Opportunities Fund II SABA Edges Higher Key Levels in Focus FACT II Acquisition Corp FACT Holds Steady at 1066 Amidst Flat Trading Session Space Asset Acquisition Corp Warrants SAAQW Rally 56 as Price Approaches Key Resistance Indian Stock Market to Remain Closed on May 28 for Bakri Id Holiday LiqTech International Inc LIQT Q1 2026 Earnings EPS Misses Estimates Amid Persistent Operational Headwinds Talon Capital Corp Warrants TLNCW Hold Steady at 050 as Key Levels Define Range PTON Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Subscriber Momentum MGRD Q1 2026 Earnings Asset Manager Posts Slight EPS Beat Amid Steady Operations FDUS Q1 2026 Earnings Strong EPS Beat Driven by Portfolio Performance Identiv Inc INVE Q1 2026 Earnings EPS Falls Short of Estimates as Company Navigates Transition PLBY Q1 2026 Earnings EPS Misses Estimates Amidst Ongoing Challenges UiPath Q1 2026 Earnings EPS Beat Drives Positive Sentiment Despite Revenue Ambiguity SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten